Fangchinoline targets human renal cell carcinoma cells through modulation of apoptotic and non‑apoptotic cell deaths-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fangchinoline targets human renal cell carcinoma cells through modulation of apoptotic and non‑apoptotic cell deaths

Published:2024-08 Issue: Volume:260 Page:155445
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Jung Young Yun,Baek Seung Ho,Um Jae-Young,Ahn Kwang Seok

Funder

National Research Foundation of Korea

Publisher

Elsevier BV

Reference106 articles.

1. J. Pandey, W. Syed, Renal Cancer. StatPearls, Treasure Island (FL) ineligible companies. Disclosure: Wajihuddin Syed declares no relevant financial relationships with ineligible companies., (2024).

2. n. National comprehensive cancer, Kidney cancer, version 3.2015;Motzer;J. Natl. Compr. Canc Netw.,2015

3. Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982-1997);Luciani;Urology,2000

4. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-updagger;Escudier;Ann. Oncol.,2019

5. Review of renal cell carcinoma and its common subtypes in radiology;Low;World J. Radio.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP